HOME•LALPATHLAB•NSE

Dr. Lal PathLabs Limited

₹1684.90

0.07%

-₹1.10 Today

07 Jul 2026, 15:30:00 IST • INR • NSE • Disclaimer

Loading chart data...

Related Stocks

ABBOTINDIA

Abbott India Limited

₹26,700.00

0.60%

AJANTPHARM

Ajanta Pharma Limited

₹3,315.00

1.73%

AKUMS

Akums Drugs and Pharmaceuticals Limited

₹653.45

4.63%

ALIVUS

Alivus Life Sciences Ltd

₹1,143.00

0.65%

ALKEM

Alkem Laboratories Limited

₹5,662.00

1.13%

APLLTD

Alembic Pharmaceuticals Limited

₹831.00

0.56%

APOLLOHOSP

Apollo Hospitals Enterprise Limited

₹8,830.00

0.66%

ASTERDM

Aster DM Healthcare Limited

₹789.80

0.22%

ASTRAZEN

AstraZeneca Pharma India Limited

₹8,344.00

1.31%

AUROPHARMA

Aurobindo Pharma Limited

₹1,583.00

0.73%

StockIN Listed Security

PREVIOUS CLOSE₹1686.00

OPEN₹1695.00

DAY RANGE₹1654.10 - ₹1718.00

YEAR RANGE₹1272.60 - ₹1803.00

MARKET CAP₹ 0 Cr

DAY VOLUME549,913

P/E RATIO55.79

EPS30.20

PRIMARY EXCHANGENSE

About

Dr Lal PathLabs Limited is an Indian service provider of diagnostic and related healthcare tests. Based in New Delhi, the company offers tests on blood, urine and other human body viscera.

Market Cap

28148.01

Total market value of outstanding shares.

EPS

30.20

Company's profit divided by outstanding shares.

P/E Ratio

55.79

Ratio of share price to its earnings per share.

83341608.00

Total number of outstanding shares.

1-Month High

1718.00

Highest price reached in the last 30 days.

1-Month Low

1610.10

Lowest price reached in the last 30 days.

52-Week High

1803.00

Highest price reached in the last year.

52-Week Low

1272.60

Lowest price reached in the last year.

Financial Statements - LALPATHLAB

	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Sales	498	497	486	503	534	489	491	541	601	539	545	602	660
Expenses	357	388	364	385	390	376	375	395	424	398	401	432	458
Operating Profit	142	109	121	118	144	113	116	146	178	141	145	170	202
OPM %	28%	22%	25%	23%	27%	23%	24%	27%	30%	26%	27%	28%	31%
Other Income	14	12	12	8	9	10	14	14	18	18	18	21	22
Interest	5	9	12	8	11	9	9	8	8	7	7	6	6
Depreciation	20	31	38	36	39	38	38	35	36	36	37	35	35
Profit before tax	131	82	84	81	103	76	83	118	152	116	120	150	183
Tax %	26%	29%	26%	28%	30%	30%	32%	29%	27%	29%	28%	28%	29%
Net Profit	96	58	62	58	72	54	57	84	111	82	86	108	131
EPS in Rs	11.40	6.88	7.35	6.92	8.60	6.33	6.80	9.90	13.09	9.74	10.12	12.75	15.46

Financial Statements - LALPATHLAB

	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Sales	498	497	486	503	534	489	491	541	601	539	545	602	660
Expenses	357	388	364	385	390	376	375	395	424	398	401	432	458
Operating Profit	142	109	121	118	144	113	116	146	178	141	145	170	202
OPM %	28%	22%	25%	23%	27%	23%	24%	27%	30%	26%	27%	28%	31%
Other Income	14	12	12	8	9	10	14	14	18	18	18	21	22
Interest	5	9	12	8	11	9	9	8	8	7	7	6	6
Depreciation	20	31	38	36	39	38	38	35	36	36	37	35	35
Profit before tax	131	82	84	81	103	76	83	118	152	116	120	150	183
Tax %	26%	29%	26%	28%	30%	30%	32%	29%	27%	29%	28%	28%	29%
Net Profit	96	58	62	58	72	54	57	84	111	82	86	108	131
EPS in Rs	11.40	6.88	7.35	6.92	8.60	6.33	6.80	9.90	13.09	9.74	10.12	12.75	15.46